Telehealth's positive impact on health outcomes in the treatment of diabetes will be discussed in a presentation by Gail Nunlee-Bland, MD, Director and Chief of Endocrinology, Diabetes Treatment Center, Howard University Hospital at the Diabetes Centers of Excellence Conference.
Alexander Hillisch, Director of Medicinal Chemistry & Head of Computational Chemistry at
Bayer to give a Featured Presentation on "Ligand and Structure-based ADMET Prediction: Tools and Applications in Lead Finding and Optimization" at the 6th Drug Design & Medicinal Chemistry Conference(June 7-8, 2012 in San Diego, CA).
G. Steven Burill, CEO, Burill &Co. will be giving a plenary keynote presentation entitled "Innovating in the New Austerity: What's Really Happening and Why Creative Dealmaking is Essential" at the Genome-wide Partnering & Deal-making conference (May 30-31, 2012 in Boston, MA).
Rab Prinjha, Interim Head of Epinova Epigenetics DPU and Head of Biology at GlaxoSmithKline will give a featured presentation on "Epigenetic Modification in the Treatment of Immunoinflammatory Diseases" at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA.
Richard Weinshilboum, Professor of Molecular Pharmacology & Experimental Therapeutics at the Mayo Clinic College of Medicine will be giving the keynote presentation entitled "Pharmacogenomics: Beyond Biomarkers".
Xybion's Harry Huss to present and lead roundtable discussions at this year's SQA Annual meeting. Xybion will also be showcasing their unique integrated preclinical and quality/compliance solutions.
Craig C. Mello, Distinguished Professor of Molecular Medicine at the University of Massachusetts Medical School and Nobel Laureate, will give a keynote presentation on "RNAi and Immortality: Recognition of Self/Non-Self Nucleic Acids" at the 3rd RNAi Research and Therapeutics Conference taking place on May 30-31, 2012 in Boston, MA.
M. J. Hampel, MPH, MBA, Senior Associate Director, Disease Specific Certification, The Joint Commission will serve as a keynote speaker at the Healthcare Centers of Excellence Summit. The Summit is scheduled May 15-17, 2012 at the Meliá Atlanta hotel.
GTC is proud to announce the Pre-Summit Workshop, "Developing a Sustainable Healthcare Business Model." The workshop to be held on May 15th, 2012 will directly precede the Healthcare Centers of Excellence Summit at the Meliá Atlanta Hotel in Atlanta, GA.
Richard Lewis, Principal Scientist, Amgen to give a Presentation on "The Discovery & Optimisation of a Novel Class of Potent, Selective and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer" at the 7th Protein Kinases in Drug Discovery Conference (May 30-31, 2012 in Boston, MA)
Trelleborg Protective Products and Radiation Shield Technologies have jointly decided to discontinue their master distributor-manufacturer relationship.
T. (Teo) Forcht Dagi, Partner at HLM Venture Partners will give a featured presentation about "Funding Opportunities and What Venture Capitalists Seek in a Diabetes Investment" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
James F. List, Vice President, Full Development Lead, Dapagliflozin, Metabolics, R&D, Bristol-Myers Squibb will participate in the panel discussion called "Beyond HbA1c - Are there Better Endpoints for Clinical Trials?" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
Other panelists in the panel discussion include Lane Desborough, Product Strategist, Medtronic,
Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism at Boehringer Ingelheim, Ingelheim, Germany, will be giving a plenary keynote presentation at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA)
Vice Presidents and Directors of Big Pharmas - Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck, Novartis, Novo Nordis, Pfizer, Roche, Sanofi and many more will speak at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA).
Ralph A. DeFronzo, MD, Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Audie L. Murphy Memorial VA Hospital in San Antonio, Texas), will be giving a presentation entitled "Treatment of T2DM Should be Based on Established Pathophysiologic Abnormalities" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
Andrew Merron Ph.D., Biosimilars Advisory Service Product Director at BioTrends (a Decision Resources Company), will be giving a featured presentation entitled "Biosimilar Opportunity within the Insulin Market" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
Peter T. Lomedico, Director of Industry Partnerships, Cure Therapies at Juvenile Diabetes Research Foundation [JDRF] will participate in the panel discussion called "Partnering with Non-Profits" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
Radiation Shield Technologies (RST) has been granted a Chinese patent for Demron®, the world's first and only fabric that provides total multi-hazard protection against nuclear, biological, chemical, bomb and ballistic threats, infrared radiation and heat. Chinese Patent No. 03824108.0 recognizes RST's unique technology.
Vice Presidents and Directors of Big Pharmas - Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck, Novartis, Novo Nordis, Pfizer, Roche, Sanofi and many more will speak at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA).
Peter T. Lomedico, Director of Industry Partnerships, Cure Therapies at Juvenile Diabetes Research Foundation [JDRF] will participate in the panel discussion called "Partnering with Non-Profits" at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
The ADA-11, an easily-installed, secure, wall-mounted door strike offered by integrated access systems manufacturer Apollo Security Systems, is setting the standard on door security access systems.
Glen Prestwich, Presidential Professor, Director,Therapeutic Biomaterials Center, Special Presidential Assistant for Faculty Entrepreneurism, Department of Medicinal Chemistry at University of Utah to give a Keynote Presentation on "Clinical Biomaterials for Regenerative Medicine: From Bench to Business" at GTC's 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA)
Devyn M. Smith, Chief Operating Officer, Neusentis Research Unit at Pfizer to give a Keynote Presentation on "The Dating Game: Finding the Right Partner" at GTC's 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA).
Satisfied Users & 
Approved Press Releases
